Results 121 to 130 of about 9,359 (237)

Conferencia de consenso: tratamiento de la diabetes tipo 2 en el paciente anciano [PDF]

, 2013
El tratamiento de la diabetes tipo 2 en el anciano representa un importante reto tanto desde el punto de vista clínico como del de la salud pública. El envejecimiento poblacional está condicionando un marcado incremento de la pandemia de diabetes en las ...
Díez Espino, Javier, Formiga, Francesc, González Sarmiento, Enrique, Gómez Huelgas, Ricardo, Lafita Tejedor, Javier, Menéndez, Edelmiro, Rodríguez Mañas, Leocadio, Sangrós, Javier   +7 more
core  

Insulin detemir for the treatment of obese patients with type 2 diabetes

Diabetes, Metabolic Syndrome and Obesity, 2012
Priscilla A Hollander1,21Baylor Endocrine Center, 2Baylor Medical Center, Dallas, Texas, USAAbstract: The risk for developing type 2 diabetes (T2DM) is greater among obese individuals. Following onset of the disease, patients with T2DM become more likely
Hollander PA
doaj  

An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog

Vascular Health and Risk Management, 2010
Katarina RaslovaMetabolic Center Ltd and Slovak Medical University, Bratislava, Slovak RepublicAbstract: Basal insulin analogs are used to minimize unpredictable processes of NPH insulin.
Katarina Raslova
doaj  

Optimization of pig models for translation of subcutaneous pharmacokinetics of therapeutic proteins: Liraglutide, insulin aspart and insulin detemir.

Translational research : the journal of laboratory and clinical medicine, 2021
K. Pedersen, A. K. J. Gradel, T. Ludvigsen, B. Christoffersen, Caroline Amalie Fuglsang-Damgaard, K. Bendtsen, S. H. Madsen, V. Manfè, H. H. Refsgaard   +8 more
semanticscholar   +1 more source

Insulin Detemir [PDF]

, 2020
openaire   +3 more sources

Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring

Diabetes, Metabolic Syndrome and Obesity, 2011
Shinya Abe1,2, Gaku Inoue1,2, Satoru Yamada1,3, Junichiro Irie1,3, Hiroyuki Nojima2, Kaoru Tsuyusaki2, Kensuke Usui2, Koichiro Atsuda2, Toshikazu Yamanouchi41Diabetes Center, Kitasato Institute Hospital, 2Center for Clinical Pharmacy and Clinical ...
Abe S, Inoue G, Yamada S, Irie J, Nojima H, Tsuyusaki K, Usui K, Atsuda K, Yamanouchi T   +8 more
doaj  

Detemir plus aspart and glulisine induced lipoatrophy: 2015 literature review and report of a new case [PDF]

, 2015

core   +1 more source

The economic prognosis of the new analog of insulin glargine usage in diabetes mellitus type 2

Качественная клиническая практика, 2018
Modelling has been performed for evaluation of economic perspectives of new insulin glargine 300 IU/ml usage for diabetes mellitus type 2 (DM2) control based on literature analysis of non-direct comparison with insulin detemir.
D. Yu. Belousov, E. V. Afanasyeva
doaj  

The role of insulin detemir in overweight type 2 diabetes management

Vascular Health and Risk Management, 2009
Yared N Demssie1, Naveed Younis2, Handrean Soran31Department of Diabetes and Endocrinology, Salford Royal Foundation NHS Trust, Salford, UK; 2Department of Medicine, University Hospital South Manchester Foundation NHS Trust, Wythenshawe, Manchester, UK ...
Yared N Demssie, Naveed Younis, Handrean Soran   +2 more
doaj  

Insulin analogues: reviewing the pros and cons in managing diabetes mellitus [PDF]

, 2011
Martin, Jennifer H., O'Moore-Sullivan, Trisha, Prins, Johannes B., Russell, Anthony   +3 more
core   +1 more source